Type I Interferon Signaling Contributes to Antitumor Immune Response and is Reduced by Imatinib in Gastrointestinal Stromal Tumor (GIST)
Year: 2019
Type: article
Institutions: New York University, University of Pennsylvania
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2981666205
